Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Karyopharm Therapeutics (KPTI) Return on Assets (2016 - 2025)

Karyopharm Therapeutics' Return on Assets history spans 13 years, with the latest figure at 0.04% for Q4 2025.

  • For Q4 2025, Return on Assets rose 40.0% year-over-year to 0.04%; the TTM value through Dec 2025 reached 0.04%, up 40.0%, while the annual FY2025 figure was 0.03%, 35.0% up from the prior year.
  • Return on Assets reached 0.04% in Q4 2025 per KPTI's latest filing, up from 1.24% in the prior quarter.
  • In the past five years, Return on Assets ranged from a high of 0.28% in Q3 2024 to a low of 1.24% in Q3 2025.
  • Average Return on Assets over 5 years is 0.38%, with a median of 0.43% recorded in 2024.
  • Peak YoY movement for Return on Assets: soared 77bps in 2024, then tumbled -152bps in 2025.
  • A 5-year view of Return on Assets shows it stood at 0.34% in 2021, then plummeted by -67bps to 0.56% in 2022, then skyrocketed by 100bps to 0.0% in 2023, then crashed by -145076bps to 0.43% in 2024, then soared by 92bps to 0.04% in 2025.
  • Per Business Quant, the three most recent readings for KPTI's Return on Assets are 0.04% (Q4 2025), 1.24% (Q3 2025), and 1.06% (Q2 2025).